We write second-day stories on the implications of that news. We craft compelling feature stories about interesting trends ...
Dr Jagadish Hiremath, a public health intellectual, says, “The normalisation of GLP-1 agonists like Ozempic and Wegovy as ...
Elcella capsules contain just three ingredients, linseed oil, also known as flaxseed, coconut oil and MCT oil, which is also ...
Hosted on MSN1d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes TreatmentThe fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase III for Overweight.
Metopimazine mesylate is under clinical development by Neurogastrx and currently in Phase II for Nausea. According to GlobalData, Phase II drugs for Nausea have a 100% phase transition success rate ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...
Artificial intelligence's potential in ophthalmology, particularly in ocular imaging, was a major focus, with debates on its ...
The year had a lot to offer, from advanced therapies aimed at Lp(a), GLP-1, and other targets, to support for simpler ...
The following is a summary of “Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback